Показать сокращенную информацию
dc.contributor.author | Ermakova A. | |
dc.contributor.author | Morozova J. | |
dc.contributor.author | Shalaeva Y. | |
dc.contributor.author | Syakaev V. | |
dc.contributor.author | Nizameev I. | |
dc.contributor.author | Kadirov M. | |
dc.contributor.author | Antipin I. | |
dc.contributor.author | Konovalov A. | |
dc.date.accessioned | 2018-04-05T07:09:27Z | |
dc.date.available | 2018-04-05T07:09:27Z | |
dc.date.issued | 2017 | |
dc.identifier.issn | 0959-9436 | |
dc.identifier.uri | http://dspace.kpfu.ru/xmlui/handle/net/129746 | |
dc.description.abstract | © 2017 The synthesis of small (2–3 nm) silver nanoparticles in the presence of new amidoaminocarboxylic tetrapentylcalix[4]resorcinarene and the binding of the antitumor drug Doxorubicin by a macrocycle in solution and on the surface of nanoparticles are described. | |
dc.relation.ispartofseries | Mendeleev Communications | |
dc.title | Calixresorcinarene-capped silver nanoparticles as new supramolecular hybrid nanocontainers | |
dc.type | Article | |
dc.relation.ispartofseries-issue | 4 | |
dc.relation.ispartofseries-volume | 27 | |
dc.collection | Публикации сотрудников КФУ | |
dc.relation.startpage | 335 | |
dc.source.id | SCOPUS09599436-2017-27-4-SID85026423426 |